These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20561127)

  • 1. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea?
    Kwon NH; Kim JE; Cho BK; Park HJ
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):368-9. PubMed ID: 20561127
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection.
    Mubki TF; Bin Dayel SA; Kadry R
    Pediatr Dermatol; 2011; 28(3):341-2. PubMed ID: 20403114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea? A comment.
    Rebora AE; Drago F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):991-2; author reply 991. PubMed ID: 21585559
    [No Abstract]   [Full Text] [Related]  

  • 4. The dermatologic manifestation of novel influenza A(H1N1).
    Vidal C; Kapelusznik L; Goldberg M; Halverstam C; Daefler S; Calfee D; Phelps RG
    Arch Dermatol; 2010 Jan; 146(1):101-2. PubMed ID: 20083711
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
    Charlier C; Enouf V; Lanternier F; Grandadam M; Amazzough K; Blanche S; Lecuit M; Lortholary O; van der Werf S
    Clin Microbiol Infect; 2009 Dec; 15(12):1189-91. PubMed ID: 19681951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyperglycemia in a H1N1 positive child on oseltamivir.
    Kulkarni R; Kinikar A
    Indian Pediatr; 2010 Sep; 47(9):812-3. PubMed ID: 21048276
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
    Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
    Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].
    Boibieux A
    Ann Fr Anesth Reanim; 2010 Feb; 29(2):85-6. PubMed ID: 20167451
    [No Abstract]   [Full Text] [Related]  

  • 9. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do immunosupressive patients really have a severe outcome with H1N1 virus infection?
    Akyüz S; Yilmaz A; Bülbül M; Erdogan O; Renda R; Demircin G
    J Trop Pediatr; 2011 Apr; 57(2):129-31. PubMed ID: 20587734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009) on a commercial airplane.
    Ooi PL; Lai FY; Low CL; Lin R; Wong C; Hibberd M; Tambyah PA
    Arch Intern Med; 2010 May; 170(10):913-5. PubMed ID: 20498421
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
    AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
    [No Abstract]   [Full Text] [Related]  

  • 15. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.
    Nguyen HT; Fry AM; Loveless PA; Klimov AI; Gubareva LV
    Clin Infect Dis; 2010 Oct; 51(8):983-4. PubMed ID: 20858074
    [No Abstract]   [Full Text] [Related]  

  • 16. More resistance to oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological response to H1N1 influenza virus infections in adults treated with oseltamivir.
    Wu UI; Liu MT; Wang JT; Hsieh SM; Chang SC; Chen YC
    Clin Infect Dis; 2010 Nov; 51(10):1223-5. PubMed ID: 20964526
    [No Abstract]   [Full Text] [Related]  

  • 19. Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.
    Singh AA
    Natl Med J India; 2009; 22(2):103. PubMed ID: 19852352
    [No Abstract]   [Full Text] [Related]  

  • 20. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.